Page last updated: 2024-08-21

oxazoles and Koch's Disease

oxazoles has been researched along with Koch's Disease in 41 studies

Research

Studies (41)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (7.32)	18.7374
1990's	1 (2.44)	18.2507
2000's	6 (14.63)	29.6817
2010's	25 (60.98)	24.3611
2020's	6 (14.63)	2.80

Authors

Authors	Studies
Bagnéris, C; Basavanakatti, VN; Bhakta, S; Bhattacharje, G; Brucoli, F; Das, AK; Das, S; Dasgupta, A; Dev, A; Dickman, R; Jalani, P; Jayaprakash, V; Kamilya, S; Mondal, A; Mukherjee, P; Naresh Babu, P; Sankaran, V; Shyam, M; Singh, A; Singh, S; Sinha, BN; Verma, H	1
Carr, W; Converse, PJ; Dartois, V; Dooley, KE; Garcia, A; Kurbatova, E; Nuermberger, EL; Stout, JE; Tasneen, R; Vernon, AA; Zimmerman, MD	1
Dheda, K; Dooley, KE; Furin, J; Gumbo, T; Maartens, G; Murray, M; Nardell, EA; Warren, RM	1
Bhakta, S; Brucoli, F; Dev, A; Jayaprakash, V; Shilkar, D; Shyam, M; Sinha, BN; Verma, H	1
Bax, HI; de Steenwinkel, JEM; Keutzer, L; Pieterman, ED; Simonsson, USH; van den Berg, S; van der Meijden, A; Wang, H; Zimmerman, MD	1
Bacchetti, P; Dheda, K; Esmail, A; Gandhi, M; Gerona, R; Huo, S; Metcalfe, J; Reckers, A	1
Kashiyama, E; Kim, S; Masuda, M; Sasabe, H; Sasahara, K; Sasaki, T; Shibata, M; Takeuchi, K; Umehara, K	1
Anderson, RF; Blaser, A; Chatelain, E; Denny, WA; Franzblau, SG; Launay, D; Ma, Z; Maes, L; Palmer, BD; Shinde, SS; Thompson, AM; Wan, B; Wang, Y	1
Aarti, C; Barbabosa-Pliego, A; Khusro, A; Salem, AZM	1
Gupta, S; Rodriguez, GM	1
Borroni, E; Cirillo, DM; Crook, DW; Cugnata, F; Davies, TJ; Fowler, PW; Gibertoni Cruz, AL; Grazian, C; Hoosdally, SJ; Peto, TEA; Rancoita, PMV; Walker, TM	1
Akkerman, O; Al-Marzouqi, NH; Aleksa, A; Alffenaar, JW; Arias-Guillén, M; Belilovski, E; Bernal, E; Boeree, MJ; Borisov, SE; Bruchfeld, J; Cadiñanos Loidi, J; Cai, Q; Caminero, JA; Cebrian Gallardo, JJ; Centis, R; Codecasa, LR; D'Ambrosio, L; Dalcolmo, M; Danila, E; Dara, M; Davidavičienė, E; Davies Forsman, L; De Los Rios Jefe, J; Denholm, J; Duarte, R; Elamin, SE; Ferrarese, M; Filippov, A; Ganatra, S; Garcia, A; García-García, JM; Gayoso, R; Giraldo Montoya, AM; Gomez Rosso, RG; Gualano, G; Hoefsloot, W; Ilievska-Poposka, B; Jonsson, J; Khimova, E; Kuksa, L; Kunst, H; Laniado-Laborín, R; Li, Y; Magis-Escurra, C; Manfrin, V; Manga, S; Marchese, V; Martínez Robles, E; Maryandyshev, A; Matteelli, A; Migliori, GB; Mullerpattan, JB; Munoz-Torrico, M; Mustafa Hamdan, H; Nieto Marcos, M; Noordin, NM; Palmero, DJ; Palmieri, F; Payen, MC; Piubello, A; Pontali, E; Pontarelli, A; Quirós, S; Rendon, A; Skrahina, A; Šmite, A; Solovic, I; Sotgiu, G; Souleymane, MB; Spanevello, A; Stošić, M; Tadolini, M; Tiberi, S; Udwadia, ZF; van den Boom, M; Vescovo, M; Viggiani, P; Visca, D; Zhurkin, D; Zignol, M	1
Danilchanka, O; Doornbos, KS; Jones, CM; Niederweis, M; Speer, A; Sun, P; Tian, C; Wells, RM; Wu, F; Xi, Z	1
Schaberg, T	1
Altman, JD; Bhati, M; Birkinshaw, RW; Cheng, TY; Gras, S; Jakobsen, S; Kalathur, RC; Kasmar, AG; Magalhaes, KG; Moody, DB; Rossjohn, J; Schiefner, A; Shires, J; Tan, LL; Turner, MT; Van Rhijn, I; Wilson, IA; Young, DC	1
Burki, T	1
Jeong, BH; Koh, WJ; Kwon, YS	1
Cho, S; Franzblau, SG; Kim, Y; Lu, Y; Ma, Z; Mdluli, K; Upton, AM; Wang, B; Wang, Y; Xu, J; Yang, TJ	1
Amoabeng, O; Mdluli, KE; Minkowski, A; Nuermberger, EL; Tasneen, R; Upton, AM; Williams, K	1
Blaser, A; Denny, WA; Franzblau, SG; Kmentova, I; Ma, Z; Palmer, BD; Sutherland, HS; Thompson, AM; Wan, B; Wang, Y	1
Baker, EN; Bulloch, EM; Chai, AF; Evans, GL; Johnston, JM; Lott, JS	1
Bloemberg, GV; Böttger, EC; Hömke, R; Keller, PM; Ritter, C; Valsesia, G	1
Adamson, J; Almeida, D; Bishai, W; Cohen, K; Dorasamy, A; Layre, E; Little, T; Moody, DB; Ndung'u, T; Pan, SJ; Patel, VB; Pym, A; Singh, R; Tapley, A; Urbanowski, M; Wallengren, K; Wilson, D; Young, DC	1
Nandicoori, VK; Samla, G; Singh, A; Soni, V; Sriram, D; Suryadevara, P; Upadhayay, S; Yogeeswari, P	1
Ahmed, Z; Bhagat, A; Kour, G; Kumar, A; Sharma, S; Singh, PP; Vishwakarma, RA	1
Dedicoat, M	1
Gao, F; Hu, M; Zheng, C	1
Chang, M; Franzblau, SG; Miller, MJ; Möllmann, U; Moraski, GC; Villegas-Estrada, A	1
Cho, S; Franzblau, SG; Kozikowski, AP; Lilienkampf, A; Pieroni, M; Wan, B; Wang, Y	1
Boshoff, HI; Checkley, L; Crumbliss, AL; Edwards, RL; Ferdig, MT; Miller, MJ; Möllmann, U; Moraski, G; Tristani, EM; Walz, AJ; Wu, C; Zhu, H	1
Chen, L; Franzblau, SG; Liu, X; Lu, X; Wan, B; You, Q; Zhou, C	1
Rodriguez, GM; Smith, I	1
Hashizume, H; Kawasaki, M; Komatsu, M; Matsumoto, M; Sasaki, H; Shimokawa, Y; Tomishige, T; Tsubouchi, H	1
Haraguchi, Y; Hashizume, H; Itotani, M; Kawasaki, M; Komatsu, M; Kuroda, H; Matsumoto, M; Sasaki, H; Tomishige, T; Tsubouchi, H	1
Brown, A; Collins, P; Matthews, PR; McDiarmid, A	1
Thorel, MF	1
Chase, S; Cynamon, MH; Klemens, SP; Sharpe, CA	1
Anderson, SW; Arain, TM; Baker, WR; Barry, CE; Kreiswirth, BN; Langhorne, MH; McMurray, DN; Sherman, DR; Stover, CK; Towell, JA; VanDevanter, DR; Warrener, P; Yuan, Y	1
Carothers, C; MacLellan, KM; Passen, S; Stabel, JR; Thornton, CG; Whitlock, RH	1
Catena, E; Marsico, SA; Ninni, A; Nitti, V	1

Reviews

9 review(s) available for oxazoles and Koch's Disease

Article	Year
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis. The Lancet. Respiratory medicine, 2019, Volume: 7, Issue:9 Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Humans; Linezolid; Nitroimidazoles; Oxazoles; Periodicals as Topic; Pulmonary Medicine; Societies, Medical; Tuberculosis; Tuberculosis, Multidrug-Resistant	2019
The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against Tuberculosis. Journal of medicinal chemistry, 2021, 01-14, Volume: 64, Issue:1 Topics: Antitubercular Agents; Bacterial Proteins; Biosynthetic Pathways; Drug Discovery; Drug Resistance, Bacterial; Humans; Iron; Mycobacterium tuberculosis; Oxazoles; Tuberculosis	2021
Neoteric advancement in TB drugs and an overview on the anti-tubercular role of peptides through computational approaches. Microbial pathogenesis, 2018, Volume: 114 Topics: Antitubercular Agents; Computational Biology; Diarylquinolines; Drug Design; Extensively Drug-Resistant Tuberculosis; Humans; Models, Molecular; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Peptides; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization	2018
Mycobacterial extracellular vesicles and host pathogen interactions. Pathogens and disease, 2018, 06-01, Volume: 76, Issue:4 Topics: Cell Wall; Dendritic Cells; Extracellular Vesicles; Host-Pathogen Interactions; Humans; Immunomodulation; Iron; Macrolides; Macrophages; Mycobacterium tuberculosis; Oxazoles; T-Lymphocytes; Tuberculosis; Virulence	2018
[Tuberculosis: new treatment options and updated recommendations]. Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:14 Topics: Antitubercular Agents; Aza Compounds; Cross-Sectional Studies; Diagnosis, Differential; Diarylquinolines; Fluoroquinolones; Germany; Humans; Moxifloxacin; Nitroimidazoles; Oxazoles; Prognosis; Quinolines; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant	2013
Tuberculosis: clinical trials and new drug regimens. Current opinion in pulmonary medicine, 2014, Volume: 20, Issue:3 Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant	2014
Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations. Drug design, development and therapy, 2016, Volume: 10 Topics: Aged; Animals; Antitubercular Agents; Arrhythmias, Cardiac; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diarylquinolines; Drug Interactions; Drug Monitoring; Humans; Hypoglycemic Agents; Middle Aged; Nitroimidazoles; Oxazoles; Polypharmacy; Risk Assessment; Risk Factors; Tuberculosis	2016
OPC-67683. Tuberculosis (Edinburgh, Scotland), 2008, Volume: 88, Issue:2 Topics: Animals; Antitubercular Agents; Humans; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis	2008
Review of the occurrence of mycobactin dependence among mycobacteria species. Annales de recherches veterinaires. Annals of veterinary research, 1984, Volume: 15, Issue:3 Topics: Animals; Columbidae; Mycobacterium; Mycobacterium avium; Nontuberculous Mycobacteria; Oxazoles; Paratuberculosis; Species Specificity; Tuberculosis; Tuberculosis, Avian	1984

Other Studies

32 other study(ies) available for oxazoles and Koch's Disease

Article	Year
Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition. Journal of medicinal chemistry, 2022, 01-13, Volume: 65, Issue:1 Topics: Animals; Antitubercular Agents; Bacterial Proteins; Calcium Channel Blockers; Ion Transport; Iron Chelating Agents; Male; Membrane Transport Proteins; Mycobacterium tuberculosis; Oxazoles; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tuberculosis; Verapamil	2022
Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models. Antimicrobial agents and chemotherapy, 2022, 04-19, Volume: 66, Issue:4 Topics: Animals; Antibiotics, Antitubercular; Antitubercular Agents; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Isoniazid; Mice; Mice, Inbred BALB C; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Rifabutin; Tuberculosis	2022
Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model. The Journal of infectious diseases, 2021, 09-17, Volume: 224, Issue:6 Topics: Animals; Antitubercular Agents; Diarylquinolines; Disease Models, Animal; Drug Therapy, Combination; Linezolid; Mice; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pyrazinamide; Recurrence; Tuberculosis	2021
Development and validation of a liquid chromatography-tandem mass spectrometry method for quantifying delamanid and its metabolite in small hair samples. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2021, Apr-15, Volume: 1169 Topics: Chromatography, Liquid; Hair; Humans; Limit of Detection; Linear Models; Nitroimidazoles; Oxazoles; Reproducibility of Results; Tandem Mass Spectrometry; Tuberculosis; Tuberculosis, Multidrug-Resistant	2021
Prediction of Human Pharmacokinetic Profiles of the Antituberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value against Extrapulmonary Tuberculosis. Antimicrobial agents and chemotherapy, 2021, 07-16, Volume: 65, Issue:8 Topics: Animals; Antitubercular Agents; Dogs; Humans; Mice; Models, Biological; Nitroimidazoles; Oxazoles; Rats; Tuberculosis	2021
6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases. Bioorganic & medicinal chemistry letters, 2017, 06-01, Volume: 27, Issue:11 Topics: Animals; Antitubercular Agents; Chagas Disease; Disease Models, Animal; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Structure-Activity Relationship; Thiazoles; Tuberculosis	2017
Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Reproducibility of Results; Tuberculosis; Tuberculosis, Multidrug-Resistant	2018
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 83 Topics: Antitubercular Agents; Diarylquinolines; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Male; Nitroimidazoles; Oxazoles; Pilot Projects; Tuberculosis; Tuberculosis, Multidrug-Resistant; World Health Organization	2019
Discovery of a siderophore export system essential for virulence of Mycobacterium tuberculosis. PLoS pathogens, 2013, Volume: 9, Issue:1 Topics: Animals; Bacterial Outer Membrane Proteins; Bacterial Proteins; Carrier Proteins; Chromatography, Thin Layer; Female; Host-Pathogen Interactions; Iron; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Oxazoles; Protein Structure, Tertiary; Receptors, Cell Surface; Sequence Deletion; Siderophores; Spleen; Survival Rate; Tuberculosis; Virulence	2013
Cutting Edge: CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo. Journal of immunology (Baltimore, Md. : 1950), 2013, Nov-01, Volume: 191, Issue:9 Topics: Antigens, CD1; Cell Line; HEK293 Cells; Humans; Lipopeptides; Lymphocyte Activation; Oxazoles; Receptors, Antigen, T-Cell; T-Cell Antigen Receptor Specificity; T-Lymphocytes; Tuberculosis	2013
Improving the health of the tuberculosis drug pipeline. The Lancet. Infectious diseases, 2014, Volume: 14, Issue:2 Topics: Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Approval; Drug Discovery; Global Health; Humans; Nitroimidazoles; Oxazoles; Research Support as Topic; Tuberculosis	2014
In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Animals; Antitubercular Agents; Caco-2 Cells; Cell Line, Tumor; Disease Models, Animal; Drug Interactions; Drug Resistance, Bacterial; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazines; Oxazoles; Tuberculosis	2015
Contribution of the nitroimidazoles PA-824 and TBA-354 to the activity of novel regimens in murine models of tuberculosis. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Animals; Antitubercular Agents; Clofazimine; Diarylquinolines; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Oxazines; Oxazoles; Pyrazinamide; Random Allocation; Tuberculosis	2015
Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Journal of medicinal chemistry, 2015, Apr-09, Volume: 58, Issue:7 Topics: Administration, Oral; Animals; Antitubercular Agents; Biological Availability; Chemistry Techniques, Synthetic; Chronic Disease; Disease Models, Animal; Humans; Male; Mice, Inbred BALB C; Mice, Inbred Strains; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Tuberculosis	2015
A covalent adduct of MbtN, an acyl-ACP dehydrogenase from Mycobacterium tuberculosis, reveals an unusual acyl-binding pocket. Acta crystallographica. Section D, Biological crystallography, 2015, Volume: 71, Issue:Pt 4 Topics: Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; Enoyl-(Acyl-Carrier Protein) Reductase (NADPH, B-Specific); Flavin-Adenine Dinucleotide; Humans; Models, Molecular; Molecular Sequence Data; Mycobacterium tuberculosis; Oxazoles; Protein Conformation; Sequence Alignment; Tuberculosis	2015
Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Antitubercular Agents; Diarylquinolines; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Reference Values; Tuberculosis; Tuberculosis, Multidrug-Resistant	2015
Biomarkers for Tuberculosis Based on Secreted, Species-Specific, Bacterial Small Molecules. The Journal of infectious diseases, 2015, Dec-01, Volume: 212, Issue:11 Topics: Adenosine; Animals; Bacterial Typing Techniques; Biomarkers; Chromatography, Liquid; Humans; Lung; Mice; Mycobacterium tuberculosis; Oxazoles; Sputum; Tandem Mass Spectrometry; Tuberculosis	2015
Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen. PLoS pathogens, 2015, Volume: 11, Issue:10 Topics: Animals; Bacterial Proteins; Benzylidene Compounds; Blotting, Western; Disease Models, Animal; Guinea Pigs; Mice; Mice, Inbred BALB C; Multienzyme Complexes; Mutagenesis, Site-Directed; Mycobacterium tuberculosis; Naphthalenes; Oxazoles; Tuberculosis	2015
Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis. Pulmonary pharmacology & therapeutics, 2016, Volume: 40 Topics: Administration, Oral; Animals; Antitubercular Agents; Area Under Curve; Biological Availability; Caco-2 Cells; Chromatography, Liquid; Dose-Response Relationship, Drug; Half-Life; Humans; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Rats; Rats, Wistar; Solubility; Tandem Mass Spectrometry; Tuberculosis	2016
Using bedaquiline and delamanid in combination and safely. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:10 Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Global Health; Humans; Nitroimidazoles; Oxazoles; Tuberculosis	2016
Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters. European journal of medicinal chemistry, 2010, Volume: 45, Issue:5 Topics: Animals; Antitubercular Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Esters; Mice; Mice, Inbred BALB C; Molecular Conformation; Mycobacterium tuberculosis; Oxazoles; Stereoisomerism; Structure-Activity Relationship; Tuberculosis	2010
NOC chemistry for tuberculosis-further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives. ChemMedChem, 2010, Oct-04, Volume: 5, Issue:10 Topics: Animals; Antitubercular Agents; Carboxylic Acids; Chlorocebus aethiops; Drug Design; Humans; Mycobacterium tuberculosis; Oxazoles; Structure-Activity Relationship; Tuberculosis; Vero Cells	2010
Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria. Journal of the American Chemical Society, 2011, Feb-23, Volume: 133, Issue:7 Topics: Antitubercular Agents; Artemisinins; Drug Design; Iron Chelating Agents; Malaria; Molecular Structure; Mycobacterium tuberculosis; Oxazoles; Tuberculosis	2011
Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2. European journal of medicinal chemistry, 2012, Volume: 49 Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteria; Bacterial Infections; Humans; Imidazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazoles; Thiazoles; Tuberculosis	2012
Identification of an ABC transporter required for iron acquisition and virulence in Mycobacterium tuberculosis. Journal of bacteriology, 2006, Volume: 188, Issue:2 Topics: Animals; ATP-Binding Cassette Transporters; Bacterial Proteins; Iron; Mice; Mice, Inbred C57BL; Mycobacterium tuberculosis; Oxazoles; Tuberculosis; Virulence	2006
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS medicine, 2006, Volume: 3, Issue:11 Topics: Animals; Antitubercular Agents; Blood; Cell Line; Humans; In Vitro Techniques; Intracellular Membranes; Macrophages; Mammals; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium; Mycobacterium bovis; Mycolic Acids; Nitroimidazoles; Oxazoles; Treatment Outcome; Tuberculosis	2006
Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles. Journal of medicinal chemistry, 2006, Dec-28, Volume: 49, Issue:26 Topics: Antitubercular Agents; Drug Resistance, Microbial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazoles; Rifampin; Structure-Activity Relationship; Tuberculosis	2006
The pathogenicity of Mycobacterium avium and related mycobacteria for experimental animals. Journal of medical microbiology, 1983, Volume: 16, Issue:1 Topics: Animals; Cattle; Chickens; Guinea Pigs; Mice; Mice, Inbred C57BL; Mycobacterium; Mycobacterium avium; Mycobacterium lepraemurium; Oxazoles; Rabbits; Tuberculosis; Tuberculosis, Avian	1983
Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:5 Topics: Acetamides; Animals; Anti-Bacterial Agents; Antitubercular Agents; Female; Linezolid; Mice; Mycobacterium tuberculosis; Oxazoles; Oxazolidinones; Tuberculosis	1999
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature, 2000, Jun-22, Volume: 405, Issue:6789 Topics: Animals; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Microbial; Drug Resistance, Multiple; Guinea Pigs; Lipids; Metronidazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Structure-Activity Relationship; Tuberculosis	2000
Application of the C(18)-carboxypropylbetaine specimen processing method to recovery of Mycobacterium avium subsp. paratuberculosis from ruminant tissue specimens. Journal of clinical microbiology, 2002, Volume: 40, Issue:5 Topics: Animals; Bacteriological Techniques; Betaine; Bison; DNA, Bacterial; Ileum; Indicators and Reagents; Kinetics; Muscle, Smooth; Mycobacterium avium; Mycobacterium Infections; Oxazoles; Polymerase Chain Reaction; Ruminants; Specimen Handling; Time Factors; Tuberculosis	2002
[Activity of terizidone in experimental tuberculosis in rabbits]. Archivio di tisiologia e delle malattie dell'apparato respiratorio, 1969, Volume: 24, Issue:9 Topics: Animals; Antitubercular Agents; Cycloserine; Drug Synergism; Kidney; Liver; Lung; Oxazoles; Oxyphenbutazone; Rabbits; Spleen; Tuberculosis	1969